SNGSF yields 11.90% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, SNGSF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SNGSF + PFE for your $10,000?
Singamas Container Holdings Limited, an investment holding company, manufactures and sells containers and other related products. It operates in two segments, Manufacturing and Logistics Services. The Manufacturing segment manufactures dry freight containers, collapsible flat rack containers, tank containers, U.S. domestic containers, offshore containers, open top containers, bitutainers, and other specialized containers and container parts. The Logistics Services segment provides container storage, repair, trucking, container/cargo handling, and other container related services; and serves as a freight station. It operates eight container depots, including seven at Dalian, Tianjin, Qingdao, Shanghai, Ningbo, Fuzhou, and Xiamen ports. The company also provides drayage, dry freight manufacturing, container leasing, management, mid-stream, property holding, and human resource management services. It operates in the United States, Korea, Hong Kong, Singapore, Europe, the People's Republic of China, the Middle East, Taiwan, and internationally. The company was incorporated in 1988 and is based in Central, Hong Kong.
Full SNGSF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.